In This Section:

◄
Review Articles
►

Amyloidosis

See more ▼
Close X
Other videos you might like

HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Video

HFA 2023 Late-breaking Science Highlights

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Video

HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana,

Watch time: 3m 11s
ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Video

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis

Michelle Kittleson,

Watch time: 6m 19s

Recent Videos

AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Video

AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 44s
AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Video

AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore,

Watch time: 8m 12s
HF 22: HELIOS-A: Vutrisiran in Patients with hATTR Amyloidosis

Video

HF 22: HELIOS-A: Vutrisiran in Patients with hATTR Amyloidosis

Watch time: 4m 42s

Radcliffe Content

Arrhythmias in Chronic Kidney Disease

European Cardiology Review 2022;17:e05.

Clinical Use of Cardiac Magnetic Resonance in Systemic Heart Disease

European Cardiology Review 2014;9(1):21–7

Review Articles

Role of T1 Mapping in Inherited Cardiomyopathies

European Cardiology Review 2016;11(2):96–101

Cardiac Amyloid – An Update

European Cardiology Review 2015;10(2):113–7